New version of CIEL dictionary added to dropbox for February 27, 2015
3 views
Skip to first unread message
Andrew Kanter
Feb 27, 2015, 10:19:46 PM2/27/15
to devel...@openmrs.org, implem...@openmrs.org
Just
wanted to let folks know that I am posting a new version of the CIEL
concept dictionary in the dropbox with versions from 1.6.6 to 1.10.0
(2.1).
Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn't work, then I will start to harass you :).
If
this is the first time you are hearing about the MVP/CIEL concept
dictionary which now comes as a standard option with the 1.9.8
standalone appliance, you can get updates from the CIEL dropbox. You can
send me an email describing your openmrs implementation, version
number, country and project.... and I will add you to the dropbox. The
2.0 standalone is compatible with CIEL but does not include the entire
dictionary.
Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary
This version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format.
This
release has new concepts added for the rapid community response to the
Ebola epidemic. This includes concepts to support Ebola treatment
centre/unit workflows, burials and new laboratory tests. I will
continue to rapidly release new versions while the epidemic is
continuing and new applications are required. I request that you let me
know about any additional concepts needed. I
also strongly recommend that people working on forms for Ebola
standardize/normalize around CIEL concepts rather than creating
unnecessary variation in concepts. This
release has new concepts added for the reference application and the FACES program.
It
also includes a separate drug table which contains all of the WHO
essential medication list drugs linked to the concept table. The plan is
to integrate these two more closely providing concept sets of drugs
which parallel the WHO classifications. The drug table may eventually
become a superset of international RxNorm encoded medications from which
you can select from. For now, it is just the WHO EML. We will keep the
SQL separate for now so that you don't have to overwrite your local drug
table when importing the CIEL concept dictionary.
The drug table was NOT updated for this release, but will be updated in next release with more formulations.
concept_id name Class Datatype description
162880 Patient withdrew consent for clinical trial Finding Coded \N
162879 Reason for admission (text) Question Text \N
162878 Number of missed medication doses in last month Question Numeric \N
162877 LMP <6 wks Question Coded \N
162877 Last menstrual period < 6 weeks prior Question Coded \N
162876 Patient has WHO class 2, 3 or 4 HIV illness Question Coded \N
162876 Patient has a HIV WHO class II, III or IV illness Question Coded \N
162875 Outcome of adverse event Question Coded \N
162874 Patient withdrawn from trial Finding Coded \N
162873 Problem resolved with sequela Misc N/A \N
162872 Active problem Misc N/A The status of a problem is active, or continuing.
162871 Adverse event reported Question Coded \N
162870 Unexpected event Question Coded \N
162869 Date/time recorded Question Datetime The date and time a particular event or date element was recorded.
162868 SIGN/SYMPTOM END DATE Question Date \N
162867 Serious adverse event Finding Coded \N
162866 Pending status Misc N/A \N
162865 Relationship to study drug Question Coded \N
162864 Possible grade 3/4 adverse event or serious adverse event Question Coded
162863 Probable Misc N/A Qualifier value for certainty
162862 Definite Misc N/A Qualifier value for certainty
162861 Sodium bicarbonate 1.26% Polyfusor Drug N/A \N
162861 Sodium bicarbonate 1.26% injection solution Drug N/A \N
162860 Phosphate Polyfusor Drug N/A \N
162860 Monopotassium phosphate 0.259% / sodium phosphate 2.9% injection solution Drug N/A \N
162859 D5 in half-normal saline Drug N/A \N
162859 Glucose 50 MG/ML / Sodium Chloride 0.0769 MEQ/ML Injectable Solution Drug N/A \N
162859 D5-1/2NS Drug N/A \N
162859 dextrose 5% / sodium chloride 0.45% Injectable Solution Drug N/A \N
162858 D10 in normal saline Drug N/A \N
162858 D10NS Drug N/A \N
162858 Glucose 100 MG/ML / Sodium Chloride 0.154 MEQ/ML Injectable Solution Drug N/A \N
162858 dextrose 10% / sodium chloride 0.9% Injectable Solution Drug N/A \N
162857 Glucose 50 MG/ML / Sodium Chloride 0.154 MEQ/ML Injectable Solution Drug N/A \N
162857 dextrose 5% / sodium chloride 0.9% Injectable Solution Drug N/A \N
162857 D5NS Drug N/A \N
162857 D5 in normal saline Drug N/A \N
162856 NS + KCL 40 mmol/L Drug N/A \N
162856 Potassium chloride 40 mmol/L in normal saline Drug N/A \N
162856 Potassium chloride 40 mmol/sodium chloride 0.9% infusion solution Drug N/A \N
162855 Potassium chloride 20 mmol/L in normal saline Drug N/A \N
162855 Potassium chloride 20 mmol/sodium chloride 0.9% infusion solution Drug N/A \N
162855 NS + KCL 20 mmol/L Drug N/A \N
162854 Medication not administered Misc N/A \N
162853 Interacting Misc N/A Qualifier value describing an action where two objects interact with one another. Also used to describe one relationship type between an adverse event and a medication.
162852 Concomitantly Misc N/A \N
162852 Concomitant Misc N/A \N
162852 Simultaneous Misc N/A \N
162851 Absolute CD4 count performed in last 6 months Question Coded \N
162850 Absolute CD4 count below guideline cutoff for initiating ART Finding Coded \N
162850 Absolute CD4 count below guideline cutoff for initiating antiretroviral therapy Finding Coded \N
162849 Woman of reproductive potential Finding Coded Whether a woman is capable of getting pregnant. Includes all aspects such as maternal age, presence of reproductive organs, etc.
162849 At risk of pregnancy Finding Coded Whether a woman is capable of getting pregnant. Includes all aspects such as maternal age, presence of reproductive organs, etc.
162848 3 day medication adherence construct ConvSet N/A A concept set used to document a patient's adherence to prescribed regimen for any particular medication over the preceding three days.
162847 Number of missed medication doses three days ago Question Numeric The number of medication doses not taken/administered three days prior to today
162846 Number of missed medication doses day before yesterday Question Numeric The number of medication doses not taken/administered during the day before yesterday.
162845 Number of expected medication doses per day Question Numeric The number of medication doses expected to be taken/administered over a typical day.
162844 Number of missed medication doses yesterday Question Numeric The number of doses of a medication that were not taken/administered during the prior day.
162843 Millimole Units of Measure N/A \N
162843 mmol Units of Measure N/A \N
162842 Micrograms per kilogram per hour Units of Measure N/A \N
162842 mcg/kg/hr Units of Measure N/A \N
162841 Milligrams per kilogram per minute Units of Measure N/A \N
162841 mg/kg/min Units of Measure N/A \N
162840 Milligrams per kilogram per hour Units of Measure N/A \N
162840 mg/kg/hr Units of Measure N/A \N
162839 International units per hour Units of Measure N/A \N
162839 IU/hr Units of Measure N/A \N
162839 International unit per hour Units of Measure N/A \N
162839 IU/h Units of Measure N/A \N
162838 mcg/kg/min Units of Measure N/A \N
162838 Micrograms per kilogram per minute Units of Measure N/A \N
162837 Outcome of Ebola care Finding Coded \N
162836 DHA+P Drug N/A \N
162836 Dihydroartemisinin / piperaquine Drug N/A \N
162836 Palaxin Drug N/A \N
162836 P.alaxin Drug N/A \N
162835 Hemolacria Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162835 Blood in tears Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162835 Bleeding from eye Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162835 Haemolacria Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162834 Save the Children Ebola stage Finding Coded \N
162834 Save the Children Ebola staging classification Finding Coded \N
162833 World Health Organization Ebola stage E Finding N/A Convalescent Ebola patient
162833 WHO Ebola stage E Finding N/A Convalescent Ebola patient
162832 World Health Organization Ebola stage D Finding N/A Physician decision to shift emphasis from resuscitative to palliative care due to poor prognostic indicators and/or failure to respond to therapy for Ebola
162832 WHO Ebola stage D Finding N/A Physician decision to shift emphasis from resuscitative to palliative care due to poor prognostic indicators and/or failure to respond to therapy for Ebola
162831 StC Ebola stage 3 Finding N/A Ebola patient with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting PLUS clinical shock, signs of organ failure, neurological involvement, and/or hemorrhage.
162831 Save the Children Ebola stage 3 Finding N/A Ebola patient with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting PLUS clinical shock, signs of organ failure, neurological involvement, and/or hemorrhage.
162831 Severe Finding N/A Ebola patient with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting PLUS clinical shock, signs of organ failure, neurological involvement, and/or hemorrhage.
162830 StC Ebola stage 2 Finding N/A Ebola patients with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting
162830 GI/Wet Finding N/A Ebola patients with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting
162830 Save the Children Ebola stage 2 Finding N/A Ebola patients with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting
162829 StC Ebola stage 1 Finding N/A Ebola patients with non-specific features: pyrexia, weakness, lethargy, myalgia
162829 Early/Dry Finding N/A Ebola patients with non-specific features: pyrexia, weakness, lethargy, myalgia
162829 Save the Children Ebola stage 1 Finding N/A Ebola patients with non-specific features: pyrexia, weakness, lethargy, myalgia
162828 Ebola disease status on admission Question Coded When the patient was admitted to the facility for this visit, were they a confirmed case, or a suspect?
162827 Ebola L gene PCR cycle threshold value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an L gene marker.
162827 Ebola L gene PCR CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an L gene marker.
162827 L gene CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an L gene marker.
162826 Ebola Np gene PCR CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an Np (nucleoprotein) gene marker.
162826 Ebola Nucleoprotein gene PCR cyclic threshold value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an Np (nucleoprotein) gene marker.
162826 Np gene CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an Np (nucleoprotein) gene marker.
162825 Breast examination (text) Finding Text \N
162824 Intraosseous Misc N/A \N
162824 Intra-osseous route Misc N/A \N
162824 Intraosseous administration Misc N/A \N
162824 Intraosseous route of administration Misc N/A \N
162823 Able to swallow any oral medication Question Coded \N
162822 Moderate to severe Misc N/A \N
162821 Mild to moderate Misc N/A \N
162820 Problem severity Finding Coded A question which identifies the severity of a problem or diagnosis. Also can be used as a convenience set.
162819 Fatal Misc N/A \N
162880 Patient withdrew consent for clinical trial Finding Coded \N
162879 Reason for admission (text) Question Text \N
162878 Number of missed medication doses in last month Question Numeric \N
162877 LMP <6 wks Question Coded \N
162877 Last menstrual period < 6 weeks prior Question Coded \N
162876 Patient has WHO class 2, 3 or 4 HIV illness Question Coded \N
162876 Patient has a HIV WHO class II, III or IV illness Question Coded \N
162875 Outcome of adverse event Question Coded \N
162874 Patient withdrawn from trial Finding Coded \N
162873 Problem resolved with sequela Misc N/A \N
162872 Active problem Misc N/A The status of a problem is active, or continuing.
162871 Adverse event reported Question Coded \N
162870 Unexpected event Question Coded \N
162869 Date/time recorded Question Datetime The date and time a particular event or date element was recorded.
162868 SIGN/SYMPTOM END DATE Question Date \N
162867 Serious adverse event Finding Coded \N
162866 Pending status Misc N/A \N
162865 Relationship to study drug Question Coded \N
162864 Possible grade 3/4 adverse event or serious adverse event Question Coded
162863 Probable Misc N/A Qualifier value for certainty
162862 Definite Misc N/A Qualifier value for certainty
162861 Sodium bicarbonate 1.26% Polyfusor Drug N/A \N
162861 Sodium bicarbonate 1.26% injection solution Drug N/A \N
162860 Phosphate Polyfusor Drug N/A \N
162860 Monopotassium phosphate 0.259% / sodium phosphate 2.9% injection solution Drug N/A \N
162859 D5 in half-normal saline Drug N/A \N
162859 Glucose 50 MG/ML / Sodium Chloride 0.0769 MEQ/ML Injectable Solution Drug N/A \N
162859 D5-1/2NS Drug N/A \N
162859 dextrose 5% / sodium chloride 0.45% Injectable Solution Drug N/A \N
162858 D10 in normal saline Drug N/A \N
162858 D10NS Drug N/A \N
162858 Glucose 100 MG/ML / Sodium Chloride 0.154 MEQ/ML Injectable Solution Drug N/A \N
162858 dextrose 10% / sodium chloride 0.9% Injectable Solution Drug N/A \N
162857 Glucose 50 MG/ML / Sodium Chloride 0.154 MEQ/ML Injectable Solution Drug N/A \N
162857 dextrose 5% / sodium chloride 0.9% Injectable Solution Drug N/A \N
162857 D5NS Drug N/A \N
162857 D5 in normal saline Drug N/A \N
162856 NS + KCL 40 mmol/L Drug N/A \N
162856 Potassium chloride 40 mmol/L in normal saline Drug N/A \N
162856 Potassium chloride 40 mmol/sodium chloride 0.9% infusion solution Drug N/A \N
162855 Potassium chloride 20 mmol/L in normal saline Drug N/A \N
162855 Potassium chloride 20 mmol/sodium chloride 0.9% infusion solution Drug N/A \N
162855 NS + KCL 20 mmol/L Drug N/A \N
162854 Medication not administered Misc N/A \N
162853 Interacting Misc N/A Qualifier value describing an action where two objects interact with one another. Also used to describe one relationship type between an adverse event and a medication.
162852 Concomitantly Misc N/A \N
162852 Concomitant Misc N/A \N
162852 Simultaneous Misc N/A \N
162851 Absolute CD4 count performed in last 6 months Question Coded \N
162850 Absolute CD4 count below guideline cutoff for initiating ART Finding Coded \N
162850 Absolute CD4 count below guideline cutoff for initiating antiretroviral therapy Finding Coded \N
162849 Woman of reproductive potential Finding Coded Whether a woman is capable of getting pregnant. Includes all aspects such as maternal age, presence of reproductive organs, etc.
162849 At risk of pregnancy Finding Coded Whether a woman is capable of getting pregnant. Includes all aspects such as maternal age, presence of reproductive organs, etc.
162848 3 day medication adherence construct ConvSet N/A A concept set used to document a patient's adherence to prescribed regimen for any particular medication over the preceding three days.
162847 Number of missed medication doses three days ago Question Numeric The number of medication doses not taken/administered three days prior to today
162846 Number of missed medication doses day before yesterday Question Numeric The number of medication doses not taken/administered during the day before yesterday.
162845 Number of expected medication doses per day Question Numeric The number of medication doses expected to be taken/administered over a typical day.
162844 Number of missed medication doses yesterday Question Numeric The number of doses of a medication that were not taken/administered during the prior day.
162843 Millimole Units of Measure N/A \N
162843 mmol Units of Measure N/A \N
162842 Micrograms per kilogram per hour Units of Measure N/A \N
162842 mcg/kg/hr Units of Measure N/A \N
162841 Milligrams per kilogram per minute Units of Measure N/A \N
162841 mg/kg/min Units of Measure N/A \N
162840 Milligrams per kilogram per hour Units of Measure N/A \N
162840 mg/kg/hr Units of Measure N/A \N
162839 International units per hour Units of Measure N/A \N
162839 IU/hr Units of Measure N/A \N
162839 International unit per hour Units of Measure N/A \N
162839 IU/h Units of Measure N/A \N
162838 mcg/kg/min Units of Measure N/A \N
162838 Micrograms per kilogram per minute Units of Measure N/A \N
162837 Outcome of Ebola care Finding Coded \N
162836 DHA+P Drug N/A \N
162836 Dihydroartemisinin / piperaquine Drug N/A \N
162836 Palaxin Drug N/A \N
162836 P.alaxin Drug N/A \N
162835 Hemolacria Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162835 Blood in tears Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162835 Bleeding from eye Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162835 Haemolacria Diagnosis N/A Haemolacria is a physical condition that causes a person to produce tears that are partially composed of blood.-Wikipedia
This is in distinction from bleeding into the eye, or under the conjunctiva.
162834 Save the Children Ebola stage Finding Coded \N
162834 Save the Children Ebola staging classification Finding Coded \N
162833 World Health Organization Ebola stage E Finding N/A Convalescent Ebola patient
162833 WHO Ebola stage E Finding N/A Convalescent Ebola patient
162832 World Health Organization Ebola stage D Finding N/A Physician decision to shift emphasis from resuscitative to palliative care due to poor prognostic indicators and/or failure to respond to therapy for Ebola
162832 WHO Ebola stage D Finding N/A Physician decision to shift emphasis from resuscitative to palliative care due to poor prognostic indicators and/or failure to respond to therapy for Ebola
162831 StC Ebola stage 3 Finding N/A Ebola patient with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting PLUS clinical shock, signs of organ failure, neurological involvement, and/or hemorrhage.
162831 Save the Children Ebola stage 3 Finding N/A Ebola patient with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting PLUS clinical shock, signs of organ failure, neurological involvement, and/or hemorrhage.
162831 Severe Finding N/A Ebola patient with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting PLUS clinical shock, signs of organ failure, neurological involvement, and/or hemorrhage.
162830 StC Ebola stage 2 Finding N/A Ebola patients with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting
162830 GI/Wet Finding N/A Ebola patients with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting
162830 Save the Children Ebola stage 2 Finding N/A Ebola patients with non-specific features (pyrexia, weakness, lethargy, myalgia) PLUS diarrhoea and/or vomiting
162829 StC Ebola stage 1 Finding N/A Ebola patients with non-specific features: pyrexia, weakness, lethargy, myalgia
162829 Early/Dry Finding N/A Ebola patients with non-specific features: pyrexia, weakness, lethargy, myalgia
162829 Save the Children Ebola stage 1 Finding N/A Ebola patients with non-specific features: pyrexia, weakness, lethargy, myalgia
162828 Ebola disease status on admission Question Coded When the patient was admitted to the facility for this visit, were they a confirmed case, or a suspect?
162827 Ebola L gene PCR cycle threshold value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an L gene marker.
162827 Ebola L gene PCR CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an L gene marker.
162827 L gene CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an L gene marker.
162826 Ebola Np gene PCR CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an Np (nucleoprotein) gene marker.
162826 Ebola Nucleoprotein gene PCR cyclic threshold value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an Np (nucleoprotein) gene marker.
162826 Np gene CT value Test Numeric Part of a test result for ebola, the CT value from a qPCR test using an Np (nucleoprotein) gene marker.
162825 Breast examination (text) Finding Text \N
162824 Intraosseous Misc N/A \N
162824 Intra-osseous route Misc N/A \N
162824 Intraosseous administration Misc N/A \N
162824 Intraosseous route of administration Misc N/A \N
162823 Able to swallow any oral medication Question Coded \N
162822 Moderate to severe Misc N/A \N
162821 Mild to moderate Misc N/A \N
162820 Problem severity Finding Coded A question which identifies the severity of a problem or diagnosis. Also can be used as a convenience set.
162819 Fatal Misc N/A \N
--------------------
Andrew S. Kanter, MD MPH FACMI
Andrew S. Kanter, MD MPH FACMI
Asst. Prof. of Clinical Biomedical Informatics and Clinical Epidemiology
Columbia University
Email: andrew...@dbmi.columbia.edu
Mobile: +1 (646) 469-2421
Office: +1 (212) 305-4842
Skype: akanter-ippnw
Yahoo: andy_kanter
Email: andrew...@dbmi.columbia.edu
Mobile: +1 (646) 469-2421
Office: +1 (212) 305-4842
Skype: akanter-ippnw
Yahoo: andy_kanter
Reply all
Reply to author
Forward
0 new messages